ADC THERAPEUTICS SA (ADCT) Stock Cash Flow
NYSE:ADCT - New York Stock Exchange, Inc. - CH0499880968 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -149.84M | -157.85M | -240.05M | -155.80M | -230.03M | |||
| Depreciation Amortization | 3.75M | 3.28M | 3.27M | 2.33M | 2.63M | |||
| Income Taxes - Deferred | N/A | 0.00 | 37.10M | -710.00K | -26.05M | |||
| Change In Working Capital | -13.75M | 5.34M | 45.88M | -65.90M | -26.39M | |||
| Interest Paid | 15.40M | 15.70M | N/A | 21.37M | 5.49M | |||
| Taxes Paid | N/A | N/A | N/A | 13.47M | 670.00K | |||
| Other non cash items | 23.77M | 25.39M | 35.12M | 83.29M | 46.46M | |||
| OPERATING CASH FLOW | -136.07M | -123.83M | -118.69M | -136.79M | -233.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -600.00K | -867.00K | -3.22M | -2.30M | -6.38M | |||
| Other Investing Activity | N/A | N/A | N/A | -210.00K | -300.00K | |||
| INVESTING CASH FLOW | -600.00K | -867.00K | -3.22M | -2.51M | -6.67M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 73.10M | -6.50M | 266.62M | |||
| Stock Issued/Repurchased | 98.13M | 98.22M | 773.00K | 5.91M | 780.00K | |||
| Other Financing Activity | N/A | -1.16M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 96.97M | 97.05M | 73.88M | -590.00K | 267.39M | |||
| Exchange Rate Effect | 121.00K | -83.00K | 184.00K | -210.00K | 10.00K | |||
| CHANGE IN CASH | -39.58M | -27.73M | -47.84M | -140.10M | 27.35M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -136.07M | -123.83M | -118.69M | -136.79M | -233.38M | |||
| Capital Expenditure | -600.00K | -867.00K | -3.22M | -2.30M | -6.38M | |||
| FREE CASH FLOW | -136.67M | -124.70M | -121.90M | -139.09M | -239.76M | |||
All data in USD